Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Muscle atrophy, a significant characteristic of congenital muscular dystrophy with laminin α2 chain deficiency (also known as MDC1A), occurs by a change in the normal balance between protein synthesis and protein degradation. The ubiquitin-proteasome system (UPS) plays a key role in protein degradation in skeletal muscle cells. In order to identify new targets for drug therapy against MDC1A, we have investigated whether increased proteasomal degradation is a feature of MDC1A. Using the generated dy(3K)/dy(3K) mutant mouse model of MDC1A, we studied the expression of members of the ubiquitin-proteasome pathway in laminin α2 chain-deficient muscle, and we treated dy(3K)/dy(3K) mice with the proteasome inhibitor MG-132. We show that members of the UPS are upregulated and that the global ubiquitination of proteins is raised in dystrophic limb muscles. Also, phosphorylation of Akt is diminished in diseased muscles. Importantly, proteasome inhibition significantly improves the dystrophic dy(3K)/dy(3K) phenotype. Specifically, treatment with MG-132 increases lifespan, enhances locomotive activity, enlarges muscle fiber diameter, reduces fibrosis, restores Akt phosphorylation and decreases apoptosis. These studies promote better understanding of the disease process in mice and could lead to a drug therapy for MDC1A patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Members of the ubiquitin-proteasome system are upregulated and the global ubiquitylation of proteins is increased in the muscles of dystrophic patients with laminin α2 chain deficiency.”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Carmignac et al., 2011
In the citing paper
“Interestingly, proteasome inhibition using MG-132 significantly improved the dystrophic phenotype (Carmignac et al., 2011).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Carmignac et al., 2011
In the citing paper
“the administration of MG-132 significantly improved the dystrophic phenotype (Carmignac et al., 2011).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Carmignac et al., 2011
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
The activation of Akt/PKB signaling pathway and cell survival
Song, G., Ouyang, G., & Bao, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00337.x · Cited by 1,888
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., & Campbell, K. P. (1992) · Nature · doi:10.1038/355696a0 · Cited by 1,410
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974
Modulation of Akt kinase activity by binding to Hsp90
Sato, S., Fujita, N., & Tsuruo, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170276797 · Cited by 967
Research works printed but not linked: 1
- Voit, 2004, The congenital muscular dystrophies, 1203
Cited by
Roberts, E. W., Deonarine, A., Jones, J. O., Denton, A. E., Feig, C., Lyons, S. K., Espeli, M., Kraman, M., McKenna, B., Wells, R. J. B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122344 · Cited by 414
“Therefore, the depletion of skeletal muscle FAP+ stromal cells was directly responsible for the loss of Fst and Lama2 in this tissue, which may reasonably be considered to be the basis of the acute increase of atrogin-1 and MuRF1 (Gomes et al., 2001).”
BackgroundInfluentialMolecular and cellular mechanisms of skeletal muscle atrophy: an update
Fanzani, A., Conraads, V. M., Penna, F., & Martinet, W. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-012-0074-6 · Cited by 370
Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies.
Sandri, M., Coletto, L., Grumati, P., & Bonaldo, P. (2013) · Journal of Cell Science · doi:10.1242/jcs.114041 · Cited by 179
“Furthermore, pharmacological inhibition of autophagy in dy3K/dy3K mice significantly improves their dystrophic phenotype (Carmignac et al., 2011a).”
BackgroundInfluentialRoles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle
Uezumi, A., Ikemoto-Uezumi, M., & Tsuchida, K. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00068 · Cited by 165
“The loss of skeletal muscle mass was attributed to the atrophy of myofibers, and was accompanied by a persistent decrease in follistatin (Fst) and laminin α2 expression and a transient increase in atrogin-1 and MuRF1 mRNA levels.”
BackgroundInfluentialLaminin-211 in skeletal muscle function
Holmberg, J., & Durbeej, M. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.22618 · Cited by 160
Self-citation
Metadata
- Authors
- Carmignac, V., Quéré, R., & Durbeej, M.
- Affiliations
- Lund University (SE)
- Corresponding author
- Carmignac, Virginie
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-17
- Volume
- 20
- Issue
- 3
- Pages
- 541-552
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2106554287
- Cited by
- 58
- References
- 53
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 3 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- MDC1A, congenital muscular dystrophy, proteasome inhibition, MG132, ubiquitin-proteasome system, muscle atrophy, protein degradation, Akt phosphorylation, ubiquitination, muscle fibrosis, apoptosis, pharmacotherapy
- MeSH terms
- Animals, Disease Models, Animal, Fluorescent Antibody Technique, Laminin, Leupeptins, Mice, Transgenic, Muscular Atrophy, Muscular Dystrophy, Animal, Phenotype, Phosphorylation, Blotting, Western, Cysteine Proteinase Inhibitors, Polymerase Chain Reaction, Apoptosis, Mice, Knockout, Muscle, Skeletal, Muscle Fibers, Skeletal, Ubiquitin, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-akt, Mice, Ubiquitination, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice. https://app.cochat.ai/papers/10.1093/hmg/ddq499
- The paper
- Carmignac, V., Quéré, R., & Durbeej, M. (2011). Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq499
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.